CAS: 1222102-29-5 - Evogliptin
Formula:C19H26F3N3O3
InChI:InChI=1S/C19H26F3N3O3/c1-19(2,3)28-10-16-18(27)24-4-5-25(16)17(26)8-12(23)6-11-7-14(21)15(22)9-13(11)20/h7,9,12,16H,4-6,8,10,23H2,1-3H3,(H,24,27)/t12-,16-/m1/s1
InChI key:InChIKey=LCDDAGSJHKEABN-MLGOLLRUSA-N
SMILES:O=C1NCCN(C(=O)CC(N)CC2=CC(F)=C(F)C=C2F)C1COC(C)(C)C
ent-Evogliptin L-Tartrate Salt
Controlled ProductCAS:1222102-29-5
Formula:
C19H26F3N3O3•C4H6O6
Color and Shape:
Neat
Molecular weight:
401.42 + 150.09
Ref: TR-E945900
75mg | 20,274.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
(3'S)-Evogliptin L-tartrate Salt
Controlled ProductCAS:1222102-29-5
Formula:
C19H26F3N3O3•C4H6O6
Color and Shape:
Neat
Molecular weight:
401.42 + 150.09
Ref: TR-E945905
50mg | 20,274.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
(4'S)-Evogliptin L-Tartrate Salt
Controlled ProductCAS:1222102-29-5
Formula:
C19H26F3N3O3•C4H6O6
Color and Shape:
Neat
Molecular weight:
401.42 + 150.09
Ref: TR-E945910
75mg | 20,138.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Evogliptin
CAS:1222102-29-5
Evogliptin is an oral anti-diabetic drug that belongs to the class of dipeptidyl peptidase-4 (DPP-4) …
Formula:
C19H26F3N3O3
Purity:
Min. 95%
Molecular weight:
401.4 g/mol
Ref: 3D-XYB10229
1mg | To inquire | ||
2mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
Evogliptin
CAS:1222102-29-5
Evogliptin (DA-1229) is an oral DPP4 inhibitor effective in reducing blood sugar and liver inflammation.
Formula:
C19H26F3N3O3
Color and Shape:
Liquid
Molecular weight:
401.42
Ref: TM-T61949
25mg | 1,437.00 € | ||
50mg | 1,872.00 € | ||
100mg | 2,364.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025